• Je něco špatně v tomto záznamu ?

Prevalence of perfusion defects detected by stress 99mtechnetium sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with breast cancer

B. Melichar, J. Doležal, V. Srámek, H. Kalábová, LK. Krčmová, R. Hyšpler, H. Studentová, M. Vošmik, M. Pecka, A. Svobodník, L. Pecen, M. Doležel, D. Solichová,

. 2014 ; 34 (7) : 3689-3694.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14074136

Grantová podpora
NT13564 MZ0 CEP - Centrální evidence projektů

AIM: The aim of the present study was to investigate myocardial perfusion in relation to disease history and laboratory parameters of atherosclerosis risk in asymptomatic patients with breast carcinoma. PATIENTS AND METHODS: One-hundred and eighty-one patients with breast carcinoma were studied. Myocardial perfusion was assessed using single-photon emission computed tomography (SPECT) with 99mtechnetium sestamibi. RESULTS: Perfusion defects were detected in 12 patients (7%). Higher body-mass index, increased concentrations of D-dimers, C-reactive protein, fibrinogen, glucose, triglycerides, and urinary albumin, a history of hypertension and of radiotherapy to the left chest wall were all associated with increased risk of perfusion defects. In a multivariate stepwise selection logistic regression model, body mass index, albuminuria and radiotherapy to the left hemithorax were significantly associated with the presence of perfusion defects. CONCLUSION: In addition to other factors, treatment history may be associated with the presence of perfusion defects in patients with breast cancer.

000      
00000naa a2200000 a 4500
001      
bmc14074136
003      
CZ-PrNML
005      
20191014084752.0
007      
ta
008      
141006s2014 gr f 000 0|eng||
009      
AR
035    __
$a (PubMed)24982388
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Melichar, Bohuslav, $u Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; Fourth Department of Medicine, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; $d 1965- $7 skuk0000853
245    10
$a Prevalence of perfusion defects detected by stress 99mtechnetium sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with breast cancer / $c B. Melichar, J. Doležal, V. Srámek, H. Kalábová, LK. Krčmová, R. Hyšpler, H. Studentová, M. Vošmik, M. Pecka, A. Svobodník, L. Pecen, M. Doležel, D. Solichová,
520    9_
$a AIM: The aim of the present study was to investigate myocardial perfusion in relation to disease history and laboratory parameters of atherosclerosis risk in asymptomatic patients with breast carcinoma. PATIENTS AND METHODS: One-hundred and eighty-one patients with breast carcinoma were studied. Myocardial perfusion was assessed using single-photon emission computed tomography (SPECT) with 99mtechnetium sestamibi. RESULTS: Perfusion defects were detected in 12 patients (7%). Higher body-mass index, increased concentrations of D-dimers, C-reactive protein, fibrinogen, glucose, triglycerides, and urinary albumin, a history of hypertension and of radiotherapy to the left chest wall were all associated with increased risk of perfusion defects. In a multivariate stepwise selection logistic regression model, body mass index, albuminuria and radiotherapy to the left hemithorax were significantly associated with the presence of perfusion defects. CONCLUSION: In addition to other factors, treatment history may be associated with the presence of perfusion defects in patients with breast cancer.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a nádory prsu $x patofyziologie $x radioizotopová diagnostika $7 D001943
650    _2
$a nemoci koronárních tepen $x patofyziologie $x radioizotopová diagnostika $7 D003324
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a radiofarmaka $x diagnostické užití $7 D019275
650    _2
$a technecium 99mTc sestamibi $x diagnostické užití $7 D017256
650    _2
$a jednofotonová emisní výpočetní tomografie $x metody $7 D015899
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Doležal, Jiří, $u Department of Nuclear Medicine, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; $d 1969- $7 xx0052087
700    1_
$a Šrámek, Vlastislav $u Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic. $7 xx0246106
700    1_
$a Kalábová, Hana $u Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic. $7 xx0240731
700    1_
$a Krčmová Kujovská, Lenka, $u Third Department of Medicine, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; Department of Analytical Chemistry, Charles University School of Pharmacy, Hradec Králové, Czech Republic. $d 1981- $7 xx0209338
700    1_
$a Hyšpler, Radomír, $u Third Department of Medicine, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; $d 1972- $7 nlk20040155091
700    1_
$a Študentová, Hana, $u Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic. $d 1979- $7 xx0122256
700    1_
$a Vošmik, Milan, $u Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; $d 1972- $7 xx0135408
700    1_
$a Pecka, Miroslav $u Fourth Department of Medicine, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; $7 ola2004212040
700    1_
$a Svobodník, Adam, $u International Clinical Research Center-Department of Clinical Development and Technology Transfer, St. Anne's University Hospital, Brno, Czech Republic. $d 1975- $7 xx0026812
700    1_
$a Pecen, Ladislav $u International Clinical Research Center-Department of Clinical Development and Technology Transfer, St. Anne's University Hospital, Brno, Czech Republic. $7 xx0102807
700    1_
$a Doležel, Martin $u Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic dolezelm@email.cz.
700    1_
$a Solichová, Dagmar $u Department of Nuclear Medicine, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; $7 xx0060526
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 34, č. 7 (2014), s. 3689-3694
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24982388 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20191014085215 $b ABA008
999    __
$a ok $b bmc $g 1042019 $s 873048
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 34 $c 7 $d 3689-3694 $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
GRA    __
$a NT13564 $p MZ0
LZP    __
$a Pubmed-20141006
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace